| Literature DB >> 31480283 |
Danlei Zhou1,2,3, Michalea Lai4,5, Aiqin Luo6, Chack-Yung Yu7,8.
Abstract
At the central region of the mammalian major histocompatibility complex (MHC) is a complement gene cluster that codes for constituents of complement C3 convertases (C2, factor B and C4). Complement activation drives the humoral effector functions for immune response. Sandwiched between the genes for serine proteinase factor B and anchor protein C4 are four less known but critically important genes coding for essential functions related to metabolism and surveillance of RNA during the transcriptional and translational processes of gene expression. These four genes are NELF-E (RD), SKIV2L (SKI2W), DXO (DOM3Z) and STK19 (RP1 or G11) and dubbed as NSDK. NELF-E is the subunit E of negative elongation factor responsible for promoter proximal pause of transcription. SKIV2L is the RNA helicase for cytoplasmic exosomes responsible for degradation of de-polyadenylated mRNA and viral RNA. DXO is a powerful enzyme with pyro-phosphohydrolase activity towards 5' triphosphorylated RNA, decapping and exoribonuclease activities of faulty nuclear RNA molecules. STK19 is a nuclear kinase that phosphorylates RNA-binding proteins during transcription. STK19 is also involved in DNA repair during active transcription and in nuclear signal transduction. The genetic, biochemical and functional properties for NSDK in the MHC largely stay as a secret for many immunologists. Here we briefly review the roles of (a) NELF-E on transcriptional pausing; (b) SKIV2L on turnover of deadenylated or expired RNA 3'→5' through the Ski-exosome complex, and modulation of inflammatory response initiated by retinoic acid-inducible gene 1-like receptor (RLR) sensing of viral infections; (c) DXO on quality control of RNA integrity through recognition of 5' caps and destruction of faulty adducts in 5'→3' fashion; and (d) STK19 on nuclear protein phosphorylations. There is compelling evidence that a dysregulation or a deficiency of a NSDK gene would cause a malignant, immunologic or digestive disease.Entities:
Keywords: 3′→5′ mRNA turnover; 5′→3′ RNA decay; DOM3Z; DXO; NELF-E; NSDK; RD; RLR; RNA quality control; RP1; SKI2W; SKIV2L; STK19; SVA; Ski complex; antiviral immunity; exosomes; hepatocellular carcinoma; interferon β; melanoma; miR1236; nuclear kinase; promoter-proximal transcriptional pause; trichohepatoenteric syndrome
Mesh:
Substances:
Year: 2019 PMID: 31480283 PMCID: PMC6769589 DOI: 10.3390/cells8091008
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1Map and gene structures of the NSDK (NELF-E, SKIV2L, DOX and STK19) quartet in the major histocompatibility complex (MHC) complement gene cluster. (A) A molecular map comparing the gene organization of human and mouse MHC complement gene cluster with RNA surveillance quartet consisting of NELF-E, SKIV2L, DXO and STK19 at the intergenic region between complement factor B and complement C4A gene. Original gene names are shown as alternatives. The mouse sequences with identities from 50–100% are plotted below the human sequences. Exons for human genes are shown as solid, purple boxes. The genomic region spanned for each gene is shaded green. The 5’ and 3’ untranslated sequences are in yellow boxes. The conserved coding sequences between human and mouse genes are highlighted in purple. Locations of CpG rich dinucleotides are shown as orange boxes. Large, repetitive retroelements SVA and endogenous retrovirus HERV-K(C4) are shown in burgundy. Arrows with solid lines represent configurations of structural genes. RP2 and TNXA are partially duplicated gene fragments. CYP21A is a pseudogene in human. Pseudogenes and gene fragments are labeled with ψ in front of gene names. Genomic DNA sequences are obtained from the following accession numbers: Human, U89335-U89337, AF019413, M59815, M59816, L26260-L26263, U07856, AF059675 and AF077974; mouse, AF030001, AF049850 and AF109906. Numberings below box represents length in human genomic DNA in kb (2k = 2 kb). The 5′ region of complement C2 gene is not well defined. Located approx. 26.4 kb upstream of the gene for C2 isoform 5 and in opposite orientation is the zinc finger and BTB domain containing protein 12 (ZBTB12). Present at the 3′ end of the C2 gene and in opposite orientation is a genetic element for long non-coding RNA (lncRNA C2-AS1, not shown). (B) Exon-intron structures of human NELF-E, SKIV2L, DXO and STK19 (modified from refs [15,16]).
Characteristics of the NSDK genes for RNA metabolism and surveillance quartet in the class III region of the human major histocompatibility complex.
| Official Symbol | Original Name; Other Earlier Names | Gene, Transcripts and Proteins (Location, cDNA, aa) | Expression | Specific Features | Function | Website |
|---|---|---|---|---|---|---|
|
| 11 exons | Ubiquitous; highest in testis | CpG rich, leucine zipper motif, RD repeats, RNA recognition motif (RRM); | A subunit of the negative RNA elongation factor that represses transcriptional elongation by RNA polymerase II |
| |
|
| 28 exons | Ubiquitous; highest in spleen | CpG rich, leucine zipper motif, helicase domain, RGD and Alu element | Unwinds RNA secondary structures, RNA turnover, antiviral defense, modulates type 1 interferon expression |
| |
|
| 7 exons | Ubiquitous; highest in testis and adrenal gland | CpG rich; leucine zipper motif | RNA quality control, decapping and 5′→3′ RNA decay |
| |
|
| 9 exons | Ubiquitous; highest in adrenal gland | Partial gene duplication in the RCCX modules; SVA (SINE - 21 CpG rich VNTRs-Alu) in intron; 8 Alu elements | Nuclear Serine/Threonine kinase |
|
Figure 2Pause and go of RNA polymerase II during transcription. (A) Schematic of conversion of the RNAPII pre-initiation complex (PIC) to a promoter proximally paused RNAPII-DSIF-NELF elongation complex (PEC) [33]. (B) Schematic showing conversion of the paused PEC to the activated RNA Pol II-DSIF-PAF-SPT6 elongation complex (EC*). SPT6, homolog of yeast suppressor of Ty6 (adapted from references [33,34], with permission from Dr. Patrick Cramer, Max Planck Institute for Biophysical Chemistry, Germany).
Figure 3Cellular localization of Skiv2l and DXO in HeLa cells under immunofluorescent microscopy. Human HeLa cells were stained by antibodies against human Skiv2l (Ski2w), nucleoli-specific B23 (nucleophosmin), anti-Xpress for HeLa transfectants with Xpress-Skiv2l fusion protein, and antibodies against DXO (Dom3z). The first three panels illustrate the presence of Skiv2l in the nucleoli and cytoplasm. The fourth and fifth panels show the dominant location of DXO (Dom3z) in the nuclei of HeLa cells. Photographs were originally taken from UV-microscope with 10 × 40 magnifications (modified from [15,52,55]).
A list of human diseases associated with mutations of SKIV2L.
| Disease | SNP | Relationship to Disease | Remarks |
|---|---|---|---|
| SLE | T allele of rs419788 in intron 6 | Confer disease susceptibility in additive pattern | One copy confers a low risk of disease and two copies result in greater susceptibility [ |
| AMD | R151Q (rs438999) | May exert a functional effect in AMD | Strong LD (linkage disequilibrium) with Bf R32Q (rs641153) [ |
| Intronic SNP (rs429608) | AMD genetic protective factors | Protective effect for AMD [ | |
| rs429608 and rs453821 | Significantly associated with neovascular AMD | Not associated significantly with PCV [ | |
| PCV | 3′UTR (rs2075702) | Significant association with PCV | Decreased risk of developing PCV [ |
| SD/THES | c.1635_1636insA (p.Gly546Argfs*35) | Deleterious mutations detected in six individuals with typical SD/THES | Molecular defects in SKIV2L cause SD/THES [ |
| c.1891G>A p.Gly631Ser | Two new mutations found in a trichohepatoenteric syndrome patient | The patient was a Malaysian child [ | |
| (c.1891G>A) (c.1120C>T) | Two variants identified in THES patients | These two mutations can cause THES [ | |
| c.1420G>T (p.Q474*) | Novel compound heterozygous nonsense mutations were identified in THES patient | Decreased levels of SKIV2L protein expression in blood mononuclear cells [ | |
| 25 exons (p.Glu1038 fs*7 (c.3112_3140del)) | A rare mutation in THES patient | This patient died at three year old [ | |
| IBD | c.354+5G>A | Identified a novel splicing mutation in a patient with IBD (ulcerative colitis) | This mutation was related to Inflammatory Bowel Disease [ |
Figure 4DXO decapping and DXO-mediated decay of NAD+-capped mRNA. (A) DXO can remove the diphosphate from a triphosphorylated cap of mRNA, the entire cap structure of an unmethylated guanosine-capped mRNA, or aberrant pre-mRNAs. (B) DXO hydrolyzes the phosphodiester linkage 3′ to the adenosine to remove the entire NAD+ moiety and generates an RNA molecule with 5′ monophosphate. Modified and redrawn from ref [89] for panel A, and ref [91] for panel B (with permission from Dr. Mike Kiledjian, Rutgers University, NJ).